Mollie May

Mollie May is a seasoned professional in pharmacovigilance with extensive experience in safety monitoring and regulatory compliance across multiple organizations. Currently serving as Director of Pharmacovigilance at Arcus Biosciences since June 2023, Mollie previously held the title of Director of Safety Science at BeiGene, focusing on patient safety in clinical trials and collaboration with cross-functional teams. Mollie's career includes roles at Amgen, bluebird bio, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, and Wyeth Pharmaceuticals, where responsibilities encompassed safety data analysis, risk management, and authoring aggregate safety reports. Education includes a Bachelor of Science in Nursing from the University of Alabama at Birmingham.